PIK3CG and neoplasm: (54) found that β-catenin can resist the effects of PI3K/AKT inhibitors, thereby reactivating FOXO proteins, and high expression levels of FOXO3 and β-catenin in human colon cancer cells can lead to tumor metastasis and decreased patient survival.